Skip to content

Improved Language Acquisition With Levodopa

Improved Language Acquisition With Levodopa

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00103805
Enrollment
20
Registered
2005-02-15
Start date
2003-03-31
Completion date
2005-08-31
Last updated
2014-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

language acquisition, plasticity, stroke recovery, associative learning

Brief summary

The purpose of this study is to determine whether the non-daily administration of levodopa is effective in boosting semantic language acquisition in healthy subjects.

Detailed description

Our prior work using a between-subject design shows that daily administration of d-amphetamine or the dopamine precursor levodopa over the course of five days markedly improves word learning success in healthy subjects. In this randomized, placebo-controlled, double-blind clinical trial, we probe whether the effect can be replicated using a within-subject design, with administration of levodopa and placebo on alternate days for a total period of 10 days. The expected scientific results will strengthen the basis for transferring neuromodulatory interventions from the laboratory to stroke patients with language dysfunctions. Because of the heterogeneity of stroke patients, only a within-subject design can be used to probe the effects of pharmacological adjuncts to language therapy.

Interventions

DRUGlevodopa

Sponsors

University Hospital Muenster
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
MALE
Age
20 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy subjects * 20-35 years old * Right handedness

Exclusion criteria

* Neurological/psychiatric/metabolic/cardiac disorders * Asthma * Known allergic reactions to one of the experimental drugs * Other drugs affecting the central nervous system * Leisure drug ingestion during the past 4 weeks (urine test) * Smoking cessation during the past 2 weeks * \> 6 cups of coffee or energy drinks per day * \> 10 cigarettes per day * \> 50 grams of alcohol per day

Design outcomes

Primary

MeasureTime frame
Boost in language learning success through levodopa compared to placebo

Secondary

MeasureTime frame
Stability of language learning success after one month

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026